The Procter & Gamble Company (NYSE:PG - Get Free Report) was down 0% during mid-day trading on Thursday . The company traded as low as $167.35 and last traded at $169.03. Approximately 1,404,281 shares changed hands during trading, a decline of 79% from the average daily volume of 6,661,686 shares. The stock had previously closed at $169.08.
Analyst Ratings Changes
Several brokerages recently weighed in on PG. Royal Bank of Canada reaffirmed a "sector perform" rating and set a $164.00 target price on shares of Procter & Gamble in a research note on Monday, October 21st. Wells Fargo & Company boosted their target price on shares of Procter & Gamble from $188.00 to $190.00 and gave the company an "overweight" rating in a research note on Friday, November 22nd. Hsbc Global Res upgraded shares of Procter & Gamble to a "strong-buy" rating in a report on Friday, October 4th. DA Davidson upgraded shares of Procter & Gamble from a "neutral" rating to a "buy" rating and boosted their price target for the company from $160.00 to $209.00 in a report on Monday, November 25th. Finally, Morgan Stanley increased their price objective on Procter & Gamble from $174.00 to $191.00 and gave the stock an "overweight" rating in a report on Monday, October 21st. Eight analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $180.45.
View Our Latest Stock Analysis on Procter & Gamble
Procter & Gamble Price Performance
The company has a market capitalization of $398.45 billion, a P/E ratio of 29.17, a PEG ratio of 3.70 and a beta of 0.44. The stock's fifty day simple moving average is $170.86 and its 200-day simple moving average is $169.74. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.75 and a quick ratio of 0.55.
Procter & Gamble (NYSE:PG - Get Free Report) last released its earnings results on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.90 by $0.03. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The firm had revenue of $21.74 billion for the quarter, compared to analyst estimates of $21.99 billion. During the same quarter last year, the firm posted $1.83 EPS. The company's revenue was down .6% on a year-over-year basis. On average, equities analysts forecast that The Procter & Gamble Company will post 6.94 earnings per share for the current fiscal year.
Procter & Gamble Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were issued a $1.0065 dividend. This represents a $4.03 dividend on an annualized basis and a yield of 2.38%. The ex-dividend date was Friday, October 18th. Procter & Gamble's dividend payout ratio (DPR) is presently 69.31%.
Insiders Place Their Bets
In other news, CEO Jon R. Moeller sold 7,007 shares of the firm's stock in a transaction dated Wednesday, October 2nd. The shares were sold at an average price of $171.65, for a total transaction of $1,202,751.55. Following the completion of the transaction, the chief executive officer now directly owns 269,172 shares of the company's stock, valued at approximately $46,203,373.80. This trade represents a 2.54 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Susan Street Whaley sold 634 shares of the company's stock in a transaction dated Wednesday, October 2nd. The shares were sold at an average price of $171.65, for a total transaction of $108,826.10. Following the completion of the sale, the insider now directly owns 19,341 shares in the company, valued at approximately $3,319,882.65. The trade was a 3.17 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 83,080 shares of company stock worth $14,629,038 in the last ninety days. Insiders own 0.18% of the company's stock.
Institutional Inflows and Outflows
Hedge funds have recently bought and sold shares of the stock. Concurrent Investment Advisors LLC boosted its holdings in shares of Procter & Gamble by 4.5% in the 3rd quarter. Concurrent Investment Advisors LLC now owns 94,109 shares of the company's stock worth $16,300,000 after acquiring an additional 4,035 shares in the last quarter. Copley Financial Group Inc. bought a new stake in shares of Procter & Gamble during the third quarter worth $668,000. Synovus Financial Corp increased its stake in shares of Procter & Gamble by 3.4% in the third quarter. Synovus Financial Corp now owns 185,134 shares of the company's stock valued at $32,065,000 after buying an additional 6,077 shares in the last quarter. Radnor Capital Management LLC bought a new position in shares of Procter & Gamble in the third quarter valued at about $5,705,000. Finally, Welch Group LLC grew its holdings in Procter & Gamble by 0.9% during the 3rd quarter. Welch Group LLC now owns 323,870 shares of the company's stock worth $56,094,000 after acquiring an additional 2,990 shares during the last quarter. 65.77% of the stock is currently owned by institutional investors and hedge funds.
Procter & Gamble Company Profile
(
Get Free Report)
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
Featured Articles
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.